Nasdaq Q2 26 Earnings Conference Call At 8:00 AM ET

Nasdaq Inc. (NDAQ) will hold a conference call at 8:00 AM ET on July 23, 2026 to discuss its Q2 2026 earnings results. This is a scheduled earnings update with no reported figures or guidance changes in the article.

Analysis

This is a low-signal event until the call prints actual guidance. For NDAQ, the market will care less about the quarter’s headline activity and more about whether recurring data/technology revenue is still compounding enough to justify a software-like multiple; if that mix is intact, any weakness in transaction-sensitive lines should be treated as transient rather than structural. The setup is asymmetric because exchange names can re-rate quickly on even small changes in forward ARR, but they can also de-rate just as fast if management sounds cautious on pipeline or pricing power.

The second-order read-through is to market-structure peers: a weak guide from NDAQ would likely pressure CBOE and ICE only if it signals broader softness in listings, volatility capture, or institutional spending, not if the miss is isolated to one-off trading items. Conversely, a clean print with stable recurring revenue would help distinguish the higher-quality data franchise from the lower-multiple execution business, which can support relative outperformance for NDAQ over the next 1-3 months. Over 6-18 months, the key question is whether the company can keep shifting mix toward durable, subscription-like revenue before market activity normalizes.

Contrarian view: consensus often overfocuses on one-quarter market volumes and underweights the compounding profile of the non-transaction businesses. That means a modest miss may be over-penalized if guidance holds, while any hint of recurring-revenue deceleration would be the real bear case and could trigger multiple compression. The main reversal catalyst would be a revived IPO/new-issue cycle or a sustained volatility regime, both of which would reaccelerate monetization and improve sentiment quickly.

Key Decisions for Investors

• Do not initiate a directional NDAQ position before the call; the event is too data-light to justify paying for uncertainty unless options are mispriced.
• If the stock sells off 3-5% post-call but management keeps forward revenue/ARR guidance intact, buy NDAQ for a 4-8 week mean-reversion trade with downside anchored to the post-earnings low.
• If recurring-revenue growth or margin guidance weakens, short NDAQ for 1-3 months or pair it versus a higher-quality market-structure peer to isolate mix risk; the thesis breaks if the next print reaccelerates ARR.
• Use the earnings call as a watch item for CBOE and ICE: a broad read-across only matters if management signals softer listings or institutional demand; otherwise avoid sector-wide positioning.